Last updated: 1 March 2024 at 4:45pm EST

James Davis Net Worth




The estimated Net Worth of J. E. Davis is at least $11 Milion dollars as of 16 March 2020. Mr. Davis owns over 3,513 units of Quest Diagnostics stock worth over $5,848,486 and over the last 10 years he sold DGX stock worth over $2,030,406. In addition, he makes $3,122,920 as Executive Vice President a General Diagnostics at Quest Diagnostics.

Mr. Davis DGX stock SEC Form 4 insiders trading

James has made over 10 trades of the Quest Diagnostics stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 3,513 units of DGX stock worth $308,266 on 16 March 2020.

The largest trade he's ever made was exercising 143,546 units of Quest Diagnostics stock on 2 January 2020 worth over $9,852,997. On average, James trades about 6,136 units every 18 days since 2014. As of 16 March 2020 he still owns at least 38,086 units of Quest Diagnostics stock.

You can see the complete history of Mr. Davis stock trades at the bottom of the page.





James Davis biography

James E. Davis serves as Executive Vice President, General Diagnostics of the Company. Mr. Rusckowski joined the Company in May 2012 as Chief Executive Officer and President and became Chairman of the Board on January 1, 2017. From October 2006 until he joined the Company, he was Chief Executive Officer of Philips Healthcare, the largest unit of Royal Philips Electronics, and a member of the Board of Management of Royal Philips Electronics and its Executive Committee. Previously, he was CEO of the Imaging Systems business of Royal Phillips Electronics. Before joining Philips in 2001, Mr. Rusckowski held numerous management positions with the healthcare division of Hewlett-Packard/Agilent Technologies. Mr. Rusckowski has been a director of the Company since May 2012. He was a director of Xerox Corporation from February 2015 to 2018, and a director of Covidien plc from December 2013 to January 2015. Mr. Rusckowski served as Chairman of the American Clinical Laboratory Association from 2014 to 2017.

What is the salary of James Davis?

As the Executive Vice President a General Diagnostics of Quest Diagnostics, the total compensation of James Davis at Quest Diagnostics is $3,122,920. There are 4 executives at Quest Diagnostics getting paid more, with Stephen Rusckowski having the highest compensation of $10,118,500.



How old is James Davis?

James Davis is 57, he's been the Executive Vice President a General Diagnostics of Quest Diagnostics since 2017. There are 14 older and 5 younger executives at Quest Diagnostics. The oldest executive at Quest Diagnostics, Inc. is Gail Wilensky, 76, who is the Independent Director.

Insiders trading at Quest Diagnostics

Over the last 21 years, insiders at Quest Diagnostics have traded over $67,426,608 worth of Quest Diagnostics stock and bought 34,000 units worth $1,910,090 . The most active insiders traders include Plc Gsk, James F Iii Flaherty a Jeffrey M Leiden. On average, Quest Diagnostics executives and independent directors trade stock every 19 days with the average trade being worth of $3,750,703. The most recent stock trade was executed by Michael E Prevoznik on 29 August 2024, trading 32,551 units of DGX stock currently worth $3,118,386.



What does Quest Diagnostics do?

quest diagnostics (nyse: dgx) empowers people to take action to improve health outcomes. derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. quest annually serves one in three adult americans and half the physicians and hospitals in the united states, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. the company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (ap) services, & interpretive consultation through its medical & scientific staff of about 900 m.d.s & ph.d.s. the company reported 2014 revenues of $7.4 billion. quest diagnostics offers the most extensive clinical testing network in the u.s., with laborator



Complete history of Mr. Davis stock trades at Quest Diagnostics

Osoba
Trans.
Transakce
Celková cena
J. E. Davis
CEO a Prezident
Prodej $308,266
16 Mar 2020
J. E. Davis
CEO a Prezident
Prodej $176,585
26 Feb 2020
J. E. Davis
CEO a Prezident
Prodej $67,413
24 Feb 2020
J. E. Davis
CEO a Prezident
Využití opce $9,852,997
2 Jan 2020
J. E. Davis
CEO a Prezident
Využití opce $2,886,790
24 Apr 2019
J. E. Davis
CEO a Prezident
Prodej $722,320
8 Apr 2019
J. E. Davis
CEO a Prezident
Prodej $517,322
2 Mar 2018
J. E. Davis
CEO a Prezident
Prodej $187,747
27 Feb 2018
J. E. Davis
CEO a Prezident
Prodej $50,754
23 Feb 2018
J. E. Davis
CEO a Prezident
Využití opce $3,332,620
2 Jan 2018


Quest Diagnostics executives and stock owners

Quest Diagnostics executives and other stock owners filed with the SEC include: